Latest Regulatory News

Mar 25, 2019 - washingtonpost.com - 0
Facebook’s Self-Proclaimed Pivot to Privacy Is Off to a Bad Start

Facebook’s self-proclaimed pivot to privacy is off to a poor start. The company disclosed last week that it had exposed hundreds of millions of users’ passwords to its employees in plain text. The mishap, a question of carelessness rather than third-party sharing, is a reminder that the data debate is as much about protection as it is about privacy. Lawmakers’ trickiest task in forging a privacy framework will be to balance companies’ legitimate interests with consumers’ rights to keep their personal information to themselves. This question is easier: There is no legitimate reason that companies should leave data unguarded from unauthorized access. Congress should make that clear.

Mar 25, 2019 - thinkprogress.org - 0
Trump Isn’t Smart Enough to Understand How the Supreme Court Is About to Disempower the Presidency

When the Supreme Court almost certainly overrules Auer in its Kisor opinion, it’s unlikely to be upfront about the shifting political winds that brought it to that decision.

Mar 25, 2019 - nytimes.com - 0
Drug Prices on TV? They May Be Coming.

The Trump administration is moving ahead with its proposal to require drug companies to disclose the often sky-high prices of their products in television commercials, despite strenuous objections and the threat of legal challenges by drug makers and TV broadcasters. The White House is reviewing the text of a final rule to impose the requirement, contending that the disclosures “will provide manufacturers with an incentive to reduce their list prices by exposing overly costly drugs to public scrutiny.”

Mar 22, 2019 - wsj.com - 0
Consumer Group Calls for FDA Moratorium on Opioid Approvals

The consumer group Public Citizen is calling on the Food and Drug Administration to issue a moratorium on new opioid-painkiller approvals, calling their message an “urgent request” in the name of public safety. In a letter to FDA Commissioner Scott Gottlieb and his boss, Health and Human Services Secretary Alex Azar, the group said that, in addition to the drug industry itself, “it is beyond question that the FDA is also culpable.” The letter was signed by Sidney M. Wolfe, founder and senior adviser to Public Citizen’s Health Research Group, and Raeford E. Brown Jr., a University of Kentucky professor who is chairman of the FDA’s advisory committee on pain products. Their letter was accompanied by a petition to the federal agency to issue the moratorium. The FDA said it would respond directly to the petitioners.

Mar 22, 2019 - politico.com - 0
Betsy DeVos Strikes Out — in Court

Education Secretary Betsy DeVos’ attempts to swiftly roll back major Obama-era policies at her agency are hitting a roadblock: federal courts. Judges have rebuffed DeVos’ attempts to change Obama policies dealing with everything from student loan forgiveness to mandatory arbitration agreements to racial disparities in special education programs. As a result, the Education Department is being forced to carry out Obama-era policies that the Trump administration had been fighting to stop — stymying DeVos’ efforts to quickly impose a conservative imprint on federal education policy over the past two years.

This Week at OIRA

Updated Fridays. Abbreviations: IFR = Interim Final Rule | PR = Proposed Rule | FR = Final Rule | RIN = Regulation Identifier Number

REGULATORY ACTIONS RECEIVED FOR REVIEW

DOC, Request for Information on Commercial Capabilities in Space Situational Awareness Data and Space Traffic Management Services, 0690-ZA03 – received 3/21/19
DOT-NHTSA, Removing Regulatory Barriers for Automated Driving Systems, Prerule, RIN: 2127-AM00received 3/14/19
DOT-PHMSA, Pipeline Safety: Safety of Hazardous Liquid Pipelines, Final Rule, RIN: 2137-AE66received 3/19/19
DOT-FMCSA, Safe Integration of Automated Driving Systems-Equipped Commercial Motor Vehicles, Prerule, RIN: 2126-AC17received 3/21/19
DOC-NOAA, Commerce Trusted Trader Program, FR, RIN: 0648-BG51received 3/19/19
EPA, Prevention of Significant Deterioration (PSD) and Nonattainment New Source Review (NSR): Project Emissions Accounting, PR, RIN: 2060-AT89received 3/21/19
HHS-CMS, Medicaid Provider Payment Reassignment, FR, RIN: 0938-AT61received 3/15/19
HHS-CMS, Regulation to Require Drug Pricing Transparency, FR, RIN: 0938-AT87received 3/18/19
HHS-CMS, Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2020, FR, RIN: 0938-AT37received 3/22/19
HUD, Applying the Fair Housing Act to Decide Whether a Person’s Request to Have an Animal as a Reasonable Accommodation Should Be Granted, Notice, RIN: 2529-ZA02 – received 3/21/19
IRS, Enrollment as an EA and EA and ERPA User Fees, FR, RIN: 1545-BO38received 3/22/19
IRS, State and Local Tax (SALT) Credits and Charitable Contributions, FR, RIN: 1545-BO89received 3/22/19
IRS, Guidance Under Sections 164 and 170(c), Notice, RIN: 1545-ZA06 – received 3/22/19
OPM, Federal Employees Health Benefits Program: Expansion of Waiver Provisions for Agencies Employing Certain Employees on Temporary Appointments and Employees on Seasonal and Intermittent Schedules, PR, RIN: 3206-AN81 – received 3/22/19
SSA, Privacy Act Exemption: Personnel Security and Sustainability Program Files, PR, RIN: 0960-AH97received 3/18/19
VA, Consent for Release of VA Medical Records, FR, RIN: 2900-AP90received 3/21/19
Received 3/18/19 – 3/22/19

REGULATORY REVIEW COMPLETED

DOL, Northern Mariana Islands U.S. Workforce Act of 2018, IFR, RIN: 1205-AB92completed 3/22/19
DOL, Regular and Basic Rates Under the Fair Labor Standards Act, PR, RIN: 1235-AA24completed 3/21/19
DOT-FAA,  Updates to Clarify and Streamline Commercial Space Transportation Regulations, PR, RIN: 2120-AL17completed 3/21/19
EPA, Federal Aluminum Aquatic Life Criteria Applicable to Oregon, PR, RIN: 2040-AF70completed 3/21/19
HHS, Head Start Service Duration Requirements, PR, RIN: 0970-AC73completed 3/14/19
HHS, Medicaid, Revisions to State Medicaid Fraud Control Unit Rules, FR, RIN: 0936-AA07completed 3/15/19
HHS-FDA, Format and Content of Reports Intended to Demonstrate Substantial Equivalence, PR, RIN: 0910-AH89completed 3/18/19
HHS-FDA, Mammography Quality Standards Act; Amendments to Part 900 Regulations, PR, RIN: 0910-AH04completed 3/18/19
Completed 3/18/19 – 3/22/19
The Coalition for Sensible Safeguards is a national alliance of more than 160 organizations, representing millions of Americans.

We are committed to strengthening public protections, encouraging sound enforcement and repelling the ongoing attacks against commonsense regulatory safeguards.

Learn more about our mission, meet our experts and view our latest press releases.